This week GSK’s ex vivo gene therapy for ADA-SCID received its marketing authorization from the European Medicine Agency. This is awesome news for the medical world and patients.
- RT @roddrury: Australia 🔘Platypuses ⚪️Gigabit Fibre ⚪️Space programme New Zealand ⚪️Platypuses 🔘Gigabit Fibre 🔘Space programme 4 weeks ago
- RT @RocketLabUSA: Made it to space. Team delighted. More to follow! #ItsaTest 4 weeks ago
- 21st Century Cures: The future of product innovation and approval pink.pharmamedtechbi.com/articles/2017/… 1 month ago
- #ASGCT17 starts! 1st up- Reading vs Writing the genome 1 month ago
- Minimizing risk in health technology innovation: A checklist shar.es/1F3xpu 2 months ago